🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Apogee Therapeutics, Inc.

APGE Healthcare
$135.07 $0 (0.00%)
Market Cap: $10.19 B
Gurus Holding
5
Popularity Rank
#1670
% of Shares Held
5.01%
Net Activity (Q3 2026)
-$93.43 M

Guru Ownership Trend

Guru Analysis for Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics, Inc. (APGE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $509.96 M.

Top institutional holders include Catherine Wood and Steven Cohen.

Institutional sentiment is currently Bearish. This is evidenced by a $93.43 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 203.9%. Conversely, Catherine Wood reduced exposure by 11.2%.

Key Holders

Recent Activity Breakdown (Q3 2026)

+$710,837.84
Total Buy Value
New Buys 0
Additions 1
-$94.14 M
Total Sell Value
Reductions 1
Sold Out 2

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Apogee Therapeutics, Inc. (APGE)

Major holders include Catherine Wood ($7.71 M), Steven Cohen ($7.24 M), Louis Moore Bacon ($2.65 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.78 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $93.43 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited APGE. The total reported sell value was $94.14 M.

Yes, 0 managers opened new positions in APGE, and 1 increased their existing holdings. The total reported buy value was $710,837.84.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.04% Reduce -11.2% 3,246,879 $7.71 M Q3 2026
0.01% New Buy 54,559 $7.24 M Q2 2026
0.04% New Buy 20,000 $2.65 M Q2 2026
0.00% Add 203.9% 446,100 $1.06 M Q3 2026
0.00% Reduce -0.9% 7,958 $1.06 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form